These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968 [TBL] [Abstract][Full Text] [Related]
4. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration. Patel SS; Goldfarb M J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391 [TBL] [Abstract][Full Text] [Related]
5. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma. Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519 [No Abstract] [Full Text] [Related]
6. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy. Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831 [TBL] [Abstract][Full Text] [Related]
7. The relationship between extent of thyroid cancer surgery and use of radioactive iodine. Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic calcification of a thyroid lobe and surrounding tissue after radioactive iodine treatment to ablate the lobe. Kim JH; Park JH; Kim SY; Bae HY Thyroid; 2011 Feb; 21(2):203-5. PubMed ID: 21186938 [TBL] [Abstract][Full Text] [Related]
9. Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma. Zgubieński K; Walczyk A; Kowalska A Endokrynol Pol; 2020; 71(3):277-278. PubMed ID: 32293702 [TBL] [Abstract][Full Text] [Related]
11. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer. Nixon IJ; Ganly I Future Oncol; 2013 Jul; 9(7):921-3. PubMed ID: 23837752 [No Abstract] [Full Text] [Related]
12. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm. Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817 [No Abstract] [Full Text] [Related]
13. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose. Lee HN; An JY; Lee KM; Kim EJ; Choi WS; Kim DY Clin Imaging; 2015; 39(3):396-400. PubMed ID: 25630229 [TBL] [Abstract][Full Text] [Related]
14. [Usefulness of low dose irradiation with 131 Iodine after thyroidectomy and before iodine radiotherapy in patients with differentiated carcinoma of the thyroid]. Rosário PW; Barroso AL; Padrão EL; Rezende LL; Purisch S Arq Bras Endocrinol Metabol; 2004 Apr; 48(2):324-5. PubMed ID: 15640891 [No Abstract] [Full Text] [Related]
15. I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer. Lin R; Banafea O; Ye J BMC Gastroenterol; 2015 May; 15():56. PubMed ID: 25947546 [TBL] [Abstract][Full Text] [Related]
16. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation. Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127 [No Abstract] [Full Text] [Related]
17. Vocal cord paralysis following I-131 ablation of a postthyroidectomy remnant. Lee TC; Harbert JC; Dejter SW; Mariner DR; VanDam J J Nucl Med; 1985 Jan; 26(1):49-50. PubMed ID: 3965651 [TBL] [Abstract][Full Text] [Related]
18. Effects of Radioactive Iodine Ablation Therapy on Voice Quality. Aydoğdu İ; Atar Y; Saltürk Z; Sarı H; Ataç E; Aydoğdu Z; İnan M; Mersinlioğlu G; Uyar Y J Voice; 2017 Jan; 31(1):94-96. PubMed ID: 27377232 [TBL] [Abstract][Full Text] [Related]
19. Selective use of radioactive iodine (RAI) in thyroid cancer: No longer "one size fits all". Marti JL; Morris LGT; Ho AS Eur J Surg Oncol; 2018 Mar; 44(3):348-356. PubMed ID: 28545679 [TBL] [Abstract][Full Text] [Related]
20. Salivary gland scintigraphy after radioiodine therapy. Malpani BL; Samuel AM; Jaiswar RK Nucl Med Commun; 1998 Feb; 19(2):183-4. PubMed ID: 9548203 [No Abstract] [Full Text] [Related] [Next] [New Search]